海辰药业
(300584)
| 流通市值：25.14亿 | | | 总市值：36.73亿 |
| 流通股本：8213.15万 | | | 总股本：1.20亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 22,884,224.56 | 71,232,354.95 | 66,190,828.11 | 76,144,155.15 |
| 应收票据及应收账款 | 238,422,128 | 194,712,286.32 | 192,055,539.76 | 165,713,558.89 |
| 其中：应收票据 | 4,083,386.94 | - | 1,615,600 | 1,630,432 |
| 应收账款 | 234,338,741.06 | 194,712,286.32 | 190,439,939.76 | 164,083,126.89 |
| 应收款项融资 | 18,409,471.95 | 17,533,974.27 | 28,095,507.73 | 18,506,680.55 |
| 预付款项 | 7,189,103.29 | 6,405,225.11 | 3,554,576.85 | 2,875,198.17 |
| 其他应收款合计 | 520,330.83 | 440,686.23 | 201,318.71 | 466,728.92 |
| 存货 | 89,879,156.85 | 85,797,591.94 | 76,575,372.32 | 76,202,433.46 |
| 其他流动资产 | 6,546,639.07 | 7,619,441.95 | 17,648,872.19 | 12,532,001.09 |
| 流动资产合计 | 383,851,054.55 | 383,741,560.77 | 384,322,015.67 | 352,440,756.23 |
| 非流动资产: | | | | |
| 长期股权投资 | 2,877,884.45 | 3,037,945.83 | 4,506,958.81 | 5,335,730.39 |
| 其他非流动金融资产 | 108,767,011.17 | 108,767,011.17 | 108,767,011.17 | 131,460,346.88 |
| 投资性房地产 | 12,597,153.8 | 12,860,102.45 | 13,123,051.1 | 13,385,999.75 |
| 固定资产 | 570,740,362.85 | 578,787,594.41 | 505,622,011.65 | 185,071,402.78 |
| 在建工程 | 290,059,798.84 | 289,010,102.93 | 356,490,519.9 | 624,638,806.01 |
| 使用权资产 | 1,135,788.03 | 1,306,156.26 | 1,476,524.49 | 1,653,965.14 |
| 无形资产 | 110,848,701.53 | 112,473,277.67 | 119,254,452.99 | 123,370,827.9 |
| 开发支出 | 1,315,104.49 | 3,579,796.52 | 2,487,317.37 | 4,996,296.32 |
| 长期待摊费用 | 134,916.32 | 155,153.78 | 175,391.24 | - |
| 递延所得税资产 | 31,992,014.54 | 35,840,824.73 | 30,981,560.85 | 28,516,201.55 |
| 其他非流动资产 | 2,088,599.34 | 2,237,497.12 | 4,884,216.24 | 12,505,304.6 |
| 非流动资产合计 | 1,132,557,335.36 | 1,148,055,462.87 | 1,147,769,015.81 | 1,130,934,881.32 |
| 资产总计 | 1,516,408,389.91 | 1,531,797,023.64 | 1,532,091,031.48 | 1,483,375,637.55 |
| 流动负债: | | | | |
| 短期借款 | 192,865,481.45 | 210,501,008.73 | 188,426,697.23 | 198,251,199.43 |
| 应付票据及应付账款 | 55,059,878.17 | 51,744,799.72 | 62,284,142.25 | 52,582,237.65 |
| 应付账款 | 55,059,878.17 | 51,744,799.72 | 62,284,142.25 | 52,582,237.65 |
| 合同负债 | 2,574,151.65 | 1,692,770.73 | 1,067,367.52 | 1,604,922.82 |
| 应付职工薪酬 | 2,945,112.89 | 1,283,946.14 | 4,345,926.83 | 352,240.86 |
| 应交税费 | 15,007,160.75 | 23,132,356.17 | 34,953,204.41 | 23,893,583.98 |
| 其他应付款合计 | 10,009,617.5 | 13,325,633.88 | 13,953,897.2 | 14,838,940 |
| 一年内到期的非流动负债 | 22,031,352.37 | 38,987,230.6 | 44,566,543.85 | 52,958,075.76 |
| 其他流动负债 | 23,265,335.66 | 19,127,871.92 | 19,339,241.92 | 5,028,276.62 |
| 流动负债合计 | 323,758,090.44 | 359,795,617.89 | 368,937,021.21 | 349,509,477.12 |
| 非流动负债: | | | | |
| 长期借款 | 62,510,000 | 46,710,000 | 53,000,000 | 45,400,000 |
| 租赁负债 | - | - | 735,253.09 | 728,272.41 |
| 递延收益 | 5,885,471.44 | 5,944,909.96 | 6,004,348.48 | 6,063,787 |
| 递延所得税负债 | 3,416,510.89 | 3,213,195.19 | 3,579,250.19 | 8,436,277.9 |
| 非流动负债合计 | 71,811,982.33 | 55,868,105.15 | 63,318,851.76 | 60,628,337.31 |
| 负债合计 | 395,570,072.77 | 415,663,723.04 | 432,255,872.97 | 410,137,814.43 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 120,000,000 | 120,000,000 | 120,000,000 | 120,000,000 |
| 资本公积 | 212,339,596.15 | 212,339,596.15 | 212,339,596.15 | 211,338,054.67 |
| 专项储备 | 275,584.76 | 129,416.49 | 165,396.24 | 605,468.23 |
| 盈余公积 | 60,000,000 | 60,000,000 | 60,000,000 | 60,000,000 |
| 未分配利润 | 680,830,429.03 | 678,128,417.18 | 660,765,445.48 | 651,385,563.69 |
| 归属于母公司股东权益合计 | 1,073,445,609.94 | 1,070,597,429.82 | 1,053,270,437.87 | 1,043,329,086.59 |
| 少数股东权益 | 47,392,707.2 | 45,535,870.78 | 46,564,720.64 | 29,908,736.53 |
| 股东权益合计 | 1,120,838,317.14 | 1,116,133,300.6 | 1,099,835,158.51 | 1,073,237,823.12 |
| 负债和股东权益合计 | 1,516,408,389.91 | 1,531,797,023.64 | 1,532,091,031.48 | 1,483,375,637.55 |
| 公告日期 | 2026-08-25 | 2026-04-25 | 2026-04-25 | 2025-10-23 |
| 审计意见(境内) | | | 标准无保留意见 | |